Spatial transcriptomics and in situ immune cell profiling of the host ectocervical landscape of HIV infected Kenyan sex working women

Front Immunol. 2024 Dec 2:15:1483346. doi: 10.3389/fimmu.2024.1483346. eCollection 2024.

Abstract

Introduction: Chronic immune activation is a hallmark of human immunodeficiency virus (HIV) infection that significantly impacts disease pathogenesis. However, in-depth studies characterizing the immunological landscape of the ectocervix during chronic HIV infection remain scarce despite the importance of this tissue site for HIV transmission.

Methods: Ectocervical tissue samples were obtained from antiretroviral-naïve HIV-seropositive and -seronegative Kenyan female sex workers. These samples were assessed by spatial transcriptomics and Gene Set Enrichment Analysis. We further performed multi-epitope ligand cartography (MELC) using an in situ staining panel that included 17 markers of primarily T cell-mediated immune responses.

Results: Spatial transcriptomics revealed tissue-wide immune activation encompassing immune responses associated with chronic HIV infection. First, both the epithelial and submucosal compartments showed diverse but significant upregulation of humoral immune responses, as indicated by the expression of several antibody-related genes. Second, an antiviral state-associated cellular immunity was also observed in the HIV-seropositive group, characterized by upregulation of genes involved in interferon signaling across the mucosal tissue and a more spatially restricted mucosal expression of genes related to T cell activity and effector functions relative to the HIV-seronegative group. Additionally, HIV associated structural alterations were evident within both compartments. Downregulated genes across the epithelium were mainly linked to epithelial integrity, with the outer layer involved in terminal differentiation and the inner layer associated with epithelial structure. MELC analysis further revealed a significantly increased ectocervical leukocyte population in HIV-seropositive participants, primarily driven by an increase in CD8+ T cells while the CD4+ T cell population remained stable. Consistent with our spatial transcriptomics data, T cells from HIV-seropositive participants showed an increased effector phenotype, defined by elevated expression of various granzymes.

Conclusion: By combining spatial transcriptomics and MELC, we identified significant HIV-associated cervical immune activity driven by induction of both T and B cell activity, together with a general antiviral state characterized by sustained interferon induction. These findings underscore that chronic HIV infection is associated with an altered ectocervical mucosal immune landscape years after primary infection. This sheds light on HIV pathogenesis at distant local sites and complements current knowledge on HIV-associated systemic immune activation.

Keywords: B cells; HIV; T cells; interferon; mucosal immunology; multi-epitope ligand cartography; spatial transcriptomics.

MeSH terms

  • Adult
  • Cervix Uteri* / immunology
  • Cervix Uteri* / virology
  • Female
  • Gene Expression Profiling
  • HIV Infections* / genetics
  • HIV Infections* / immunology
  • HIV Infections* / virology
  • HIV-1 / immunology
  • Humans
  • Kenya
  • Sex Workers*
  • Transcriptome*

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Funding was provided by the Karolinska Institutet faculty funds for the graduate program in international ranking (MFB), the Swedish Physicians Against AIDS Foundation (MFB, VK), the Swedish Research Council (VR-V 2021-02671, KB), and the Canadian Institutes of Health Research (CIHR, MOP #86721, KRF). The project also received funding from the European Union’s Horizon 2020 Research and Innovation program under grant agreement no. 847943 (MISTRAL; KB, ADB). AEH was supported by Deutsche Forschungsgemeinschaft (DFG) grants HA5354/8-2 (part of priority program 1937, Project number 320406065) and HA5354/10-1 (Project number 457352540). APR was supported by the MCIN/AEI/10.13039/501100011033 and FSE+ (RYC2022-035848-I) and the MICIU/AEI/10.13039/501100011033/ FEDER/UE (PID2023-148687OB-I00).